Samuel Myllykangas

Samuel Myllykangas

Gründer bei Blueprint Genetics Oy

Health Technology
Consumer Services
Commercial Services

Ursprung des Netzwerks ersten Grades von Samuel Myllykangas

EinheitArt der EinheitIndustrie
14
Subsidiary Biotechnology 14

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Samuel Myllykangas

UnternehmenSektorVerknüpfte PersonenHauptposition
University of Helsinki College/University

Tuomas Ristonpoika Kosonen

Ville Samuel Koskenvuo

Tommi Lehtonen

Undergraduate Degree

Graduate Degree

Graduate Degree

Medical Specialties

Hilde Furberg

Corporate Officer/Principal

Miscellaneous Commercial Services

Hilde Furberg

Director/Board Member

SEDANA MEDICAL AB Medical Specialties

Hilde Furberg

Director/Board Member

HERANTIS PHARMA OYJ Pharmaceuticals: Major

Hilde Furberg

Director/Board Member

Biotechnology

Hilde Furberg

Director/Board Member

ONCOZENGE AB Pharmaceuticals: Major

Hilde Furberg

Director/Board Member

Tappin AS

Hilde Furberg

Director/Board Member

COMBIGENE AB Pharmaceuticals: Major

Hilde Furberg

Director/Board Member

PCI BIOTECH HOLDING ASA Biotechnology

Hilde Furberg

Director/Board Member

Real Estate Development

Hilde Furberg

Corporate Officer/Principal

BERGENBIO ASA Pharmaceuticals: Major

Hilde Furberg

Chairman

AFFYMETRIX, INC. Medical Specialties

Gary Zweiger

Corporate Officer/Principal

Baxter Medical AB

Hilde Furberg

Corporate Officer/Principal

CALLIDITAS THERAPEUTICS AB Pharmaceuticals: Major

Hilde Furberg

Director/Board Member

WEIFA ASA Pharmaceuticals: Major

Hilde Furberg

Director/Board Member

Pharmaceuticals: Major

Hilde Furberg

Corporate Officer/Principal

University of Oslo College/University

Hilde Furberg

Graduate Degree

Financial Conglomerates

Hilde Furberg

Director/Board Member

PROBI AB Biotechnology

Hilde Furberg

Director/Board Member

Financial Conglomerates

Ann-Christine Sundell

Director/Board Member

BIONANO GENOMICS, INC. Biotechnology

Gary Zweiger

Corporate Officer/Principal

AGILENT TECHNOLOGIES, INC. Miscellaneous Commercial Services

Gary Zweiger

Corporate Officer/Principal

Medical Specialties

Gary Zweiger

Corporate Officer/Principal

CONVATEC GROUP PLC Medical Specialties

Erik Jan Zimmer

Corporate Officer/Principal

Computer Processing Hardware

Risto Sakari Kankaanpää

Chief Executive Officer

Investment Managers

Risto Sakari Kankaanpää

Private Equity Investor

University of Turku College/University

Juha Koskenvuo

Doctorate Degree

Information Technology Services

Tero-Pekka Alastalo

President

Investment Managers

David Germonpré

Private Equity Investor

Packaged Software

David Germonpré

Director/Board Member

Industrial Machinery

David Germonpré

Director/Board Member

Electronic Production Equipment

David Germonpré

Director/Board Member

Investment Managers

David Germonpré

Private Equity Investor

Medical Specialties

Erik Jan Zimmer

Chief Operating Officer

MBA Institute College/University

Erik Jan Zimmer

Undergraduate Degree

Au Media AB

Ann-Christine Sundell

Director/Board Member

Medical Specialties

Erik Jan Zimmer

Corporate Officer/Principal

Medical Specialties

Erik Jan Zimmer

Director/Board Member

College/University

Erik Jan Zimmer

Masters Business Admin

Medical Specialties

Erik Jan Zimmer

Corporate Officer/Principal

BIOMÉRIEUX Medical Specialties

Erik Jan Zimmer

Corporate Officer/Principal

Medical/Nursing Services

Gary Zweiger

Consultant / Advisor

Financial Conglomerates

Gary Zweiger

Founder

Statistik

International

Vereinigte Staaten 13
Norwegen 11
Finnland 10
Schweden 7
Belgien 5

Sektoral

Health Technology 25
Finance 8
Consumer Services 6
Commercial Services 5
Electronic Technology 3

Operativ

Director/Board Member 64
Corporate Officer/Principal 19
Chairman 14
Independent Dir/Board Member 10
Private Equity Investor 9
  1. Börse
  2. Insiders
  3. Samuel Myllykangas
  4. Unternehmensverbindungen
-40 % Einmalige Verlängerung: Unsere Abonnements führen Sie zu den besten Investitionen von morgen
PROFITIEREN SIE JETZT